CDC to meet on rare heart inflammation after COVID vaccine

An anonymous reader quotes a Reuters report: The Centers for Disease Control and Prevention announced Thursday that will convene an “emergency meeting” of its advisers on June 18 to discuss the rare but higher than expected reports of heart inflammation after doses of Pfizer and Moderna mRNA-based COVID-19 vaccines. So far, the CDC has identified 226 reports that could meet the agency’s “working case definition” for myocarditis and pericarditis in the aftermath of the shootings, the agency disclosed Thursday. The vast majority have recovered, but 41 had persistent symptoms, 15 are still hospitalized and 3 are in intensive care. Reports represent only a tiny fraction of the nearly 130 million Americans who have been fully immunized with doses of Pfizer or Moderna.

“It’s a bit of a comparison of apples to oranges because, again, these are preliminary reports. Not all of them will turn out to be true reports of myocarditis or pericarditis,” warned Dr Tom Shimabukuro, an official. vaccine safety from CDC. Shimabukuro said their findings were mostly “consistent” with reports of rare cases of heart inflammation that had been investigated in Israel and reported by the US Department of Defense earlier this year. The CDC is working on more data and analysis on the reports ahead of its own advisers’ emergency meeting next week, he said, and also plans to analyze the risk of heart inflammation posed by the capture of COVID-19. The new details about myocarditis and pericarditis first appeared in presentations to a panel of independent advisers for the Food and Drug Administration, who are meeting Thursday to discuss how the regulator should approach emergency use authorization for the use of COVID-19 vaccines in young children.

CDC to meet on rare heart inflammation after COVID vaccine

Source link CDC to meet on rare heart inflammation after COVID vaccine

Back to top button